TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 105 filers reported holding TG THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $201,000 | – | 20,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 1,647,000 | $6,423,000 | 0.45% |
| DAFNA Capital Management LLC | 75,000 | $293,000 | 0.30% |
| Baker Brothers Advisors | 2,199,656 | $8,579,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 71,105 | $277,000 | 0.05% |
| SMITH ASSET MANAGEMENT GROUP LP | 196,684 | $767,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 66,000 | $257,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,000 | $4,000 | 0.01% |
| COLUMBUS CIRCLE INVESTORS | 161,919 | $631,000 | 0.00% |
| JENNISON ASSOCIATES LLC | 455,271 | $1,776,000 | 0.00% |
| BlackRock Fund Advisors | 448,445 | $1,749,000 | 0.00% |